Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

July 1, 2021; Volume 62,Issue 7

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 7A;

Errata

  • You have access
    Errata
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 1015;

Discussions with Leaders

  • You have access
    Perspectives on Radiopharmaceutical Agents from the FDA
    Lou Marzella, Johannes Czernin and Thomas Hope
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 881-883; DOI: https://doi.org/10.2967/jnumed.121.262450

Hot Topics

  • You have access
    Pharmacogenomics in Radionuclide Therapy: Impact on Response to Theranostics
    Andrew M. Scott and Lisa Bodei
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 884-885; DOI: https://doi.org/10.2967/jnumed.120.254995

Continuing Education

  • You have access
    The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 2: Nodular Goiter, Hypothyroidism, and Subacute Thyroiditis
    Giuliano Mariani, Massimo Tonacchera, Mariano Grosso, Emilio Fiore, Pierpaolo Falcetta, Lucia Montanelli, Brunella Bagattini, Paolo Vitti and H. William Strauss
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 886-895; DOI: https://doi.org/10.2967/jnumed.120.251504

Focus on Molecular Imaging

  • You have access
    Imaging Immunometabolism in Atherosclerosis
    Philip Z. Mannes and Sina Tavakoli
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 896-902; DOI: https://doi.org/10.2967/jnumed.120.245407

Special Contribution

  • INVITED PERSPECTIVE

    • You have access
      The Disappearing Act of Nuclear Medicine in The Netherlands: Just a New Trick by the Great Harry Houdini?
      Czernin Johannes and Herrmann Ken
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 903-904; DOI: https://doi.org/10.2967/jnumed.121.262190
  • You have access
    The New Integrated Nuclear Medicine and Radiology Residency Program in The Netherlands: Why Do Residents Choose to Subspecialize in Nuclear Medicine and Why Not?
    Ton Velleman, Walter Noordzij, Rudi A.J.O. Dierckx, Yfke Ongena and Thomas C. Kwee
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 905-909; DOI: https://doi.org/10.2967/jnumed.120.261503

Covid Commentaries

  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
    Open Access
    Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
    Ganna Blazhenets, Nils Schroeter, Tobias Bormann, Johannes Thurow, Dirk Wagner, Lars Frings, Cornelius Weiller, Philipp T. Meyer, Andrea Dressing and Jonas A. Hosp
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 910-915; DOI: https://doi.org/10.2967/jnumed.121.262128

Editorial

  • You have access
    Nuclear Medicine Beyond VISION
    Wolfgang P. Fendler, Ken Herrmann and Matthias Eiber
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 916-917; DOI: https://doi.org/10.2967/jnumed.121.262441

Oncology

  • Clinical

    • You have access
      Early Treatment Response Assessment Using 18F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
      Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 918-925; DOI: https://doi.org/10.2967/jnumed.120.254243
    • FEATURED CLINICAL INVESTIGATION ARTICLE

      • Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non–Small Cell Lung Cancer: Comparison of Assessment Methods
        You have access
        Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non–Small Cell Lung Cancer: Comparison of Assessment Methods
        Narjess Ayati, Sze Ting Lee, S. Rasoul Zakavi, Melissa Cheng, W.F. Eddie Lau, Sagun Parakh, Kunthi Pathmaraj and Andrew M. Scott
        Journal of Nuclear Medicine July 1, 2021, 62 (7) 926-933; DOI: https://doi.org/10.2967/jnumed.120.254508
    • <sup>11</sup>C-Sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for Early Evaluation of Sorafenib Therapy
      You have access
      11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy
      Lemonitsa H. Mammatas, Maqsood Yaqub, N. Harry Hendrikse, Otto S. Hoekstra, Richard J. Honeywell, Robert C. Schuit, Martijn Meijerink, Lothar A. Schwarte, Godefridus J. Peters, Henk M.W. Verheul, Adriaan A. Lammertsma and C. Willemien Menke-van der Houven van Oordt
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 934-940; DOI: https://doi.org/10.2967/jnumed.120.251611
  • Basic

    • You have access
      PARP1: A Potential Molecular Marker to Identify Cancer During Colposcopy Procedures
      Paula Demétrio de Souza França, Navjot Guru, Abigail R. Kostolansky, Audrey Mauguen, Giacomo Pirovano, Susanne Kossatz, Sheryl Roberts, Marcio Abrahão, Snehal G. Patel, Kay J. Park, Thomas Reiner and Elizabeth Jewell
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 941-948; DOI: https://doi.org/10.2967/jnumed.120.253575
    • Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
      You have access
      Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies
      Ning Zhao, Yangjie Huang, Yung-hua Wang, Ryan K. Muir, Ying-Chu Chen, Junnian Wei, Nima Hooshdaran, Pavithra Viswanath, Youngho Seo, Davide Ruggero, Adam R. Renslo and Michael J. Evans
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 949-955; DOI: https://doi.org/10.2967/jnumed.120.252460
    • BRIEF COMMUNICATION

      • Imaging Calreticulin for Early Detection of Immunogenic Cell Death During Anticancer Treatment
        You have access
        Imaging Calreticulin for Early Detection of Immunogenic Cell Death During Anticancer Treatment
        Dong-Yeon Kim, Ayoung Pyo, Misun Yun, Ramar Thangam, Sung-Hwan You, Ying Zhang, Ye-rim Jung, Dinh-Huy Nguyen, Akhil Venu, Hyeon Sik Kim, Mee Sun Yoon, Yeongjin Hong and Jung-Joon Min
        Journal of Nuclear Medicine July 1, 2021, 62 (7) 956-960; DOI: https://doi.org/10.2967/jnumed.120.245290

Theranostics

  • Clinical

    • Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging
      You have access
      Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging
      Dennie Meijer, Maarten L. Donswijk, Yves J.L. Bodar, Pim J. van Leeuwen, Henk G. van der Poel, Wouter V. Vogel, Jakko A. Nieuwenhuijzen, N. Harry Hendrikse, Daniela E. Oprea-Lager and André N. Vis
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 961-967; DOI: https://doi.org/10.2967/jnumed.120.252528
    • Positive Predictive Value and Correct Detection Rate of <sup>18</sup>F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
      You have access
      Positive Predictive Value and Correct Detection Rate of 18F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
      Maythinee Chantadisai, Gabriel Buschner, Markus Krönke, Isabel Rauscher, Thomas Langbein, Stephan G. Nekolla, Kilian Schiller, Matthias M. Heck, Tobias Maurer, Alexander Wurzer, Hans-Juergen Wester, Calogero D’Alessandria, Wolfgang Weber and Matthias Eiber
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 968-974; DOI: https://doi.org/10.2967/jnumed.120.255661
    • BRIEF COMMUNICATION

      • First Experiences with <sup>177</sup>Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single Patients
        You have access
        First Experiences with 177Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single Patients
        Vikas Prasad, Friedemann Zengerling, Jochen P. Steinacker, Christian Bolenz, Meinrad Beer, Thomas Wiegel, Matthias Eiber, Neil Fleshner and Ambros J. Beer
        Journal of Nuclear Medicine July 1, 2021, 62 (7) 975-978; DOI: https://doi.org/10.2967/jnumed.120.249029
  • Basic

    • Preclinical Evaluation of <sup>213</sup>Bi- and <sup>225</sup>Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer
      You have access
      Preclinical Evaluation of 213Bi- and 225Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer
      Sangeeta Ray Banerjee, Ala Lisok, Il Minn, Anders Josefsson, Vivek Kumar, Mary Brummet, Srikanth Boinapally, Cory Brayton, Ronnie C. Mease, George Sgouros, Robert F. Hobbs and Martin G. Pomper
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 980-988; DOI: https://doi.org/10.2967/jnumed.120.256388
    • FEATURED ARTICLE OF THE MONTH

      • Mechanisms of Resistance to Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
        You have access
        Mechanisms of Resistance to Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
        Andreea D. Stuparu, Joseph R. Capri, Catherine A.L. Meyer, Thuc M. Le, Susan L. Evans-Axelsson, Kyle Current, Mark Lennox, Christine E. Mona, Wolfgang P. Fendler, Jeremie Calais, Matthias Eiber, Magnus Dahlbom, Johannes Czernin, Caius G. Radu, Katharina Lückerath and Roger Slavik
        Journal of Nuclear Medicine July 1, 2021, 62 (7) 989-995; DOI: https://doi.org/10.2967/jnumed.120.256263

Cardiovascular

  • Clinical

    • BRIEF COMMUNICATION

      • Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
        You have access
        Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence
        Toshihiko Goto, Shohei Kikuchi, Kento Mori, Takafumi Nakayama, Hidekatsu Fukuta, Yoshihiro Seo, Hitomi Narita, Akihiko Iida and Nobuyuki Ohte
        Journal of Nuclear Medicine July 1, 2021, 62 (7) 996-998; DOI: https://doi.org/10.2967/jnumed.120.253419

Neurology

  • Clinical

    • Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs Study
      You have access
      Toward a Universal Readout for 18F-Labeled Amyloid Tracers: The CAPTAINs Study
      Gérard N. Bischof, Peter Bartenstein, Henryk Barthel, Bart van Berckel, Vincent Doré, Thilo van Eimeren, Norman Foster, Jochen Hammes, Adriaan A. Lammertsma, Satoshi Minoshima, Chris Rowe, Osama Sabri, John Seibyl, Koen Van Laere, Rik Vandenberghe, Victor Villemagne, Igor Yakushev and Alexander Drzezga
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 999-1005; DOI: https://doi.org/10.2967/jnumed.120.250290

Radiobiology/Dosimetry

  • Clinical

    • Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
      You have access
      Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
      Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Böning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim
      Journal of Nuclear Medicine July 1, 2021, 62 (7) 1006-1011; DOI: https://doi.org/10.2967/jnumed.120.254656

Radiochemistry

  • Basic

    • BRIEF COMMUNICATION

      • Cyclotron-Produced <sup>132</sup>La as a PET Imaging Surrogate for Therapeutic <sup>225</sup>Ac
        You have access
        Cyclotron-Produced 132La as a PET Imaging Surrogate for Therapeutic 225Ac
        Eduardo Aluicio-Sarduy, Todd E. Barnhart, Jamey Weichert, Reinier Hernandez and Jonathan W. Engle
        Journal of Nuclear Medicine July 1, 2021, 62 (7) 1012-1015; DOI: https://doi.org/10.2967/jnumed.120.255794

Challenging Case Studies

  • You have access
    Liver Enzyme Elevation After 177Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer
    Hannes Treiber, Alexander König, Albrecht Neesse, Annika Richter, Carsten Oliver Sahlmann and Arne Strauss
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 1016-1019; DOI: https://doi.org/10.2967/jnumed.120.258533

Letters to the Editor

  • You have access
    Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19
    Ekaterina Dadachova
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 1020; DOI: https://doi.org/10.2967/jnumed.120.261874
  • You have access
    Reply: Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19
    Nagavarakishore Pillarsetty, Lukas M. Carter, Jason S. Lewis and Thomas Reiner
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 1020-1021; DOI: https://doi.org/10.2967/jnumed.121.261950
  • You have access
    The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate Cancer
    Carlo Andrea Bravi, Nicola Fossati, Giorgio Gandaglia, Nazareno Suardi, Francesco Montorsi and Alberto Briganti
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 1021; DOI: https://doi.org/10.2967/jnumed.121.262104
  • You have access
    Reply: The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate Cancer
    Wolfgang Peter Fendler and Andrea Farolfi
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 1022; DOI: https://doi.org/10.2967/jnumed.121.262271
  • You have access
    V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy
    Wolfgang M. Schaefer, D. Knollmann and Philipp T. Meyer
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 1022-1024; DOI: https://doi.org/10.2967/jnumed.120.261263

SNMMI Newsline

  • You have access
    2021 SNMMI Image of the Year
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 9N;
  • You have access
    New Officers for SNMMI and SNMMI-TS
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 10N-11N;
  • You have access
    JNM Editors’ Choice Awards for 2020
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 12N;
  • You have access
    2021 Henry N. Wagner, Jr., MD, SNMMI Annual Meeting Best Paper of the Year
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 12N;
  • You have access
    Outstanding JNMT Articles for 2020
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 13N;
  • You have access
    First Symposium of the European Working Group on the Radiobiology of Molecular Radiotherapy
    Bart Cornelissen, Samantha Terry, Julie Nonnekens and Jean-Pierre Pouget; European Working Group on the Radiobiology of Molecular Radiotherapy
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 14N-15N;
  • You have access
    Nuclear Medicine Innovations: Providing Access for All
    Richard Wahl
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 16N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 17N-18N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 19N-20N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (7)
Journal of Nuclear Medicine
Vol. 62, Issue 7
July 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Mechanisms of Resistance to Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
  • Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non–Small Cell Lung Cancer: Comparison of Assessment Methods
Sign up for alerts

Jump to

  • This Month in JNM
  • Errata
  • Discussions with Leaders
  • Hot Topics
  • Continuing Education
  • Focus on Molecular Imaging
  • Special Contribution
    • INVITED PERSPECTIVE
  • Covid Commentaries
  • Editorial
  • Oncology
    • Clinical
      • FEATURED CLINICAL INVESTIGATION ARTICLE
    • Basic
      • BRIEF COMMUNICATION
  • Theranostics
    • Clinical
      • BRIEF COMMUNICATION
    • Basic
      • FEATURED ARTICLE OF THE MONTH
  • Cardiovascular
    • Clinical
      • BRIEF COMMUNICATION
  • Neurology
    • Clinical
  • Radiobiology/Dosimetry
    • Clinical
  • Radiochemistry
    • Basic
      • BRIEF COMMUNICATION
  • Challenging Case Studies
  • Letters to the Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire